2m 2m 2m 2m 2m 2m 2m
TANGO THERAPETCS (TNGX)
NASDAQ
$23.10-$1.36 (-5.54%)
Price as of Oct 02, 2026 4:59 PM EDT- $4.1BMarket Cap
- 217.95%1-Year Change
- BiotechnologyIndustry
TANGO THERAPETCS (TNGX)
$23.10-$1.36 (-5.54%)
TNGX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $24.45 | ||
Change | -$0.50 (-2.00%) | ||
Open | $24.90 | ||
High | $25.43 | ||
Low | $23.95 | ||
Previous Close | $24.95 | ||
Volume | 2,910,264 | ||
30-Day Average Volume | 2,985,195 | ||
1-Week Change | -0.73% | ||
1-Month Change | 9.40% | ||
1-Year Change | 217.95% | ||
3-Year Change | 117.14% | ||
5-Year Change | 85.93% | ||
Fundamentals | |||
Shares Outstanding | 168.6M | ||
Total Assets | $1.1B | ||
Market Cap | $4.1B | ||
Enterprise Value | $3.8B | ||
Period: QTR TTM FY | |||
Revenue | $0.00 | ||
Net Income | -$55.3M | ||
Free Cash Flow | -$38.8M | ||
EBIT | -$55.3M | ||
EBITDA | -$54.9M | ||
Net Working Capital | $1.0B | ||
EPS | -$0.37 | ||
Enterprise Value/EBITDA | -69 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 4 | ||
P/E | -66 | ||
PEG | 4 | ||
Price/Free Cash Flow | -106 | ||
Price/Operating Cash Flow | -106 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue